Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

lymphokine-activated killer cell therapy

Known as: LAK cell therapy, cell therapy, lymphokine-activated killer, therapy, lymphokine-activated killer cell 
The use of lymphokine-activated killer cells in the treatment of any disease or disorder.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Natural killer (NK) cells have been considered to be a group of lymphocytes lacking clonally distributed receptors for antigens… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2004
2004
SummaryInterleukin-1 (Il-1)-like activity in biological fluids was measured by their ability to rectify the Il-1-dependent… Expand
  • figure 1
  • table 1
Review
2003
Review
2003
IL-21 is a recently described type I cytokine produced by activated CD4(+) T cells that profoundly affects the growth, survival… Expand
Highly Cited
1997
Highly Cited
1997
Lymphoreticular malignancies, collectively called posttransplant lymphoproliferative disorders (PTLD), eventually develop in 2-5… Expand
1997
1997
Abstract Cell lymphomas which often contain the Epstein-Barr virus (EBV) make up the preponderance of tumors that collectively… Expand
1996
1996
The conserved lymphokine elements-0 (CLE0) in the IL5 promoter is essential for the expression of IL-5. Here, we report the… Expand
Highly Cited
1995
Highly Cited
1995
Twenty-three patients with pleural mesothelioma stage I-IIA were entered in a study of continuous daily intrapleural infusion of… Expand
  • table I
  • table II
  • figure 1
1994
1994
The effects of NG-methyl-L-arginine (L-NMA), an inhibitor of nitric oxide formation, were studied in dogs treated with… Expand
Highly Cited
1990
Highly Cited
1990
Several groups have described the efficacy of interleukin 2 (IL-2) plus lymphokine-activated killer (LAK) cells in the treatment… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
1989
Highly Cited
1989
The phenotype and function of lymphocytes from cancer patients treated with repetitive weekly cycles of continuous i.v. infusions… Expand